4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Veracyte, Inc. (VCYT) operates in the Diagnostics & Research industry and is headquartered in South San Francisco, United States with about 755 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, VCYT reported $517M in revenue and $66M in net income.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
Interactive charts & full statements → Open the VCYT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $517M | $446M | $361M | $296M | — |
| Gross Profit | $362M | $298M | $230M | $176M | — |
| Operating Income (EBIT) | $78M | $20M | ($17M) | ($35M) | — |
| Net Income | $66M | $24M | ($74M) | ($37M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $139M | $141M | $132M | $130M | $114M | — |
| Gross Profit | $101M | $102M | $91M | $90M | $80M | — |
| Operating Income (EBIT) | $23M | $40M | $23M | $14M | $3M | — |
| Net Income | $29M | $41M | $19M | ($1M) | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.4B | $1.3B | $1.1B | $1.2B | — |
| Total Liabilities | $96M | $124M | $71M | $81M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VCYT viewer.
About TickerBase · Data methodology & sources